Ex McKesson CEO named Quidel chairman
Executive Summary
Former Sandoz Pharma and McKesson CEO Mark Pulido has been named chairman of Quidel, the diagnostics firm announced June 2. Pulido, 51, has been a director of Quidel for two years and was most recently chairman and CEO of BenefitPoint, Inc. Pulido resigned as head of McKesson in 1999 following the disclosure of reporting irregularities associated with the wholesaler's merger with the health information firm HBOC (1"The Pink Sheet" June 28, 1999, p. 6)...